HAO
HAO
Haoxi Health Technology LimitedIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $8.85M ▼ | $2.32M ▲ | $4.11M ▲ | 46.44% ▲ | $1.42 ▲ | $4.2M ▲ |
| Q2-2025 | $23.95M ▼ | $607.74K ▼ | $-232.53K ▼ | -0.97% ▼ | $-0.01 ▼ | $11.61K ▼ |
| Q4-2024 | $25.02M ▲ | $650.11K ▲ | $529.8K ▼ | 2.12% ▼ | $0.04 ▼ | $959.42K ▲ |
| Q2-2024 | $23.5M ▲ | $383.02K ▼ | $760.2K ▲ | 3.23% ▲ | $0.06 ▲ | $829.96K ▲ |
| Q4-2023 | $19.07M | $614.25K | $522.71K | 2.74% | $0.04 | $709.71K |
What's going well?
The company posted a headline profit, and non-operating income provided a big boost. Tax and interest costs remain low, so any turnaround in the core business could quickly improve results.
What's concerning?
Sales collapsed, costs are out of control, and the only reason for profit is a one-off gain outside the main business. Operating losses are growing, and the business looks unsustainable without more non-operating windfalls.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $8.62M ▼ | $21.6M ▼ | $4.22M ▲ | $17.38M ▼ |
| Q2-2025 | $9.1M ▲ | $22.07M ▲ | $3.32M ▼ | $18.74M ▲ |
| Q4-2024 | $6.66M ▲ | $15.51M ▲ | $4.23M ▼ | $11.27M ▲ |
| Q2-2024 | $1.11M ▼ | $6.17M ▲ | $4.45M ▲ | $1.72M ▲ |
| Q4-2023 | $1.2M | $4.46M | $2.9M | $1.57M |
What's financially strong about this company?
HAO has much more cash than debt, very high liquidity, and almost no risky assets like goodwill. Its equity base is strong, and most assets are easy to turn into cash if needed.
What are the financial risks or weaknesses?
Receivables and payables have both jumped, which could mean customers are paying slower or the company is taking longer to pay suppliers. Equity and cash dipped slightly, and debt increased, though still at low levels.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $4.11M ▲ | $-1.11M ▲ | $-505.18K ▲ | $1.16M ▼ | $-477.96K ▼ | $-1.1M ▲ |
| Q2-2025 | $-232.53K ▼ | $-2.25M ▼ | $-3.07M ▲ | $7.75M ▼ | $2.44M ▼ | $-2.26M ▼ |
| Q4-2024 | $531.47K ▼ | $-1.05M ▼ | $-3.11M ▼ | $9.08M ▲ | $5.54M ▲ | $-1.09M ▼ |
| Q2-2024 | $760.2K ▲ | $301K ▲ | $-16.16K ▲ | $239.4K ▲ | $1.11M ▲ | $284.84K ▲ |
| Q4-2023 | $522.71K | $-1.08M | $-41.88K | $-153K | $-622.38K | $-1.12M |
What's strong about this company's cash flow?
Cash burn is shrinking, showing some improvement in operations. The company still has $8.6 million in cash, giving it a bit of breathing room.
What are the cash flow concerns?
HAO is not generating cash from its business and relies on selling new shares to survive. Shareholders are being diluted, and the company will need more outside funding soon if losses continue.
5-Year Trend Analysis
A comprehensive look at Haoxi Health Technology Limited's financial evolution and strategic trajectory over the past five years.
The company has several notable positives: a transformed balance sheet with strong cash reserves and low leverage; a clear niche focus in healthcare digital advertising; proprietary technology and established platform relationships; and a track record of rapid historical growth and improving reported earnings through 2024. Its asset-light model and strong liquidity give it flexibility to experiment with new services such as livestreaming without immediate financing stress.
The most significant risks center on operations and cash. Revenue has become volatile, with a sharp drop in the latest year. Operating profit has turned negative, overhead has surged, and gross profits have come under pressure, pointing to execution or demand challenges. Cash flow from operations and free cash flow have been negative for several years, leaving the company reliant on equity financing. In addition, regulatory uncertainty in healthcare advertising, intense competition, and the need to continually refresh technology all add to the risk profile.
The outlook is mixed and uncertain. On one hand, Haoxi sits in a growing structural niche with differentiated capabilities, a strong liquidity cushion, and promising innovation in tools and livestreaming services. On the other, the current business model is not yet generating reliable operating profits or cash, and recent financial trends have moved in the wrong direction. Future performance will depend on the company’s ability to stabilize revenue, rein in costs, convert its specialized offerings into recurring, high-quality business, and turn accounting profits into sustainable cash flows.
About Haoxi Health Technology Limited
https://www.haoximedia.comHaoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $8.85M ▼ | $2.32M ▲ | $4.11M ▲ | 46.44% ▲ | $1.42 ▲ | $4.2M ▲ |
| Q2-2025 | $23.95M ▼ | $607.74K ▼ | $-232.53K ▼ | -0.97% ▼ | $-0.01 ▼ | $11.61K ▼ |
| Q4-2024 | $25.02M ▲ | $650.11K ▲ | $529.8K ▼ | 2.12% ▼ | $0.04 ▼ | $959.42K ▲ |
| Q2-2024 | $23.5M ▲ | $383.02K ▼ | $760.2K ▲ | 3.23% ▲ | $0.06 ▲ | $829.96K ▲ |
| Q4-2023 | $19.07M | $614.25K | $522.71K | 2.74% | $0.04 | $709.71K |
What's going well?
The company posted a headline profit, and non-operating income provided a big boost. Tax and interest costs remain low, so any turnaround in the core business could quickly improve results.
What's concerning?
Sales collapsed, costs are out of control, and the only reason for profit is a one-off gain outside the main business. Operating losses are growing, and the business looks unsustainable without more non-operating windfalls.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $8.62M ▼ | $21.6M ▼ | $4.22M ▲ | $17.38M ▼ |
| Q2-2025 | $9.1M ▲ | $22.07M ▲ | $3.32M ▼ | $18.74M ▲ |
| Q4-2024 | $6.66M ▲ | $15.51M ▲ | $4.23M ▼ | $11.27M ▲ |
| Q2-2024 | $1.11M ▼ | $6.17M ▲ | $4.45M ▲ | $1.72M ▲ |
| Q4-2023 | $1.2M | $4.46M | $2.9M | $1.57M |
What's financially strong about this company?
HAO has much more cash than debt, very high liquidity, and almost no risky assets like goodwill. Its equity base is strong, and most assets are easy to turn into cash if needed.
What are the financial risks or weaknesses?
Receivables and payables have both jumped, which could mean customers are paying slower or the company is taking longer to pay suppliers. Equity and cash dipped slightly, and debt increased, though still at low levels.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $4.11M ▲ | $-1.11M ▲ | $-505.18K ▲ | $1.16M ▼ | $-477.96K ▼ | $-1.1M ▲ |
| Q2-2025 | $-232.53K ▼ | $-2.25M ▼ | $-3.07M ▲ | $7.75M ▼ | $2.44M ▼ | $-2.26M ▼ |
| Q4-2024 | $531.47K ▼ | $-1.05M ▼ | $-3.11M ▼ | $9.08M ▲ | $5.54M ▲ | $-1.09M ▼ |
| Q2-2024 | $760.2K ▲ | $301K ▲ | $-16.16K ▲ | $239.4K ▲ | $1.11M ▲ | $284.84K ▲ |
| Q4-2023 | $522.71K | $-1.08M | $-41.88K | $-153K | $-622.38K | $-1.12M |
What's strong about this company's cash flow?
Cash burn is shrinking, showing some improvement in operations. The company still has $8.6 million in cash, giving it a bit of breathing room.
What are the cash flow concerns?
HAO is not generating cash from its business and relies on selling new shares to survive. Shareholders are being diluted, and the company will need more outside funding soon if losses continue.
5-Year Trend Analysis
A comprehensive look at Haoxi Health Technology Limited's financial evolution and strategic trajectory over the past five years.
The company has several notable positives: a transformed balance sheet with strong cash reserves and low leverage; a clear niche focus in healthcare digital advertising; proprietary technology and established platform relationships; and a track record of rapid historical growth and improving reported earnings through 2024. Its asset-light model and strong liquidity give it flexibility to experiment with new services such as livestreaming without immediate financing stress.
The most significant risks center on operations and cash. Revenue has become volatile, with a sharp drop in the latest year. Operating profit has turned negative, overhead has surged, and gross profits have come under pressure, pointing to execution or demand challenges. Cash flow from operations and free cash flow have been negative for several years, leaving the company reliant on equity financing. In addition, regulatory uncertainty in healthcare advertising, intense competition, and the need to continually refresh technology all add to the risk profile.
The outlook is mixed and uncertain. On one hand, Haoxi sits in a growing structural niche with differentiated capabilities, a strong liquidity cushion, and promising innovation in tools and livestreaming services. On the other, the current business model is not yet generating reliable operating profits or cash, and recent financial trends have moved in the wrong direction. Future performance will depend on the company’s ability to stabilize revenue, rein in costs, convert its specialized offerings into recurring, high-quality business, and turn accounting profits into sustainable cash flows.
CEO
Lei Xu
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-01-27 | Reverse | 1:25 |
Ratings Snapshot
Rating : S-